Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAF1 | P04049 | 13/20 | 0.41 |
| ▸ | BRAF | P15056 | 13/20 | 0.41 |
| ▸ | MAPK14 | Q16539 | 4/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4727004 | 0.88 | RAF1 (0.43) | RAF1BRAFMAPK14 | |
| SCHEMBL4727823 | 0.85 | MAPK14 (0.45) | RAF1BRAFMAPK14 | |
| SCHEMBL4728370 | 0.85 | MAPK14 (0.45) | RAF1BRAFMAPK14 | |
| SCHEMBL4727320 | 0.84 | CNR2 (0.42) | RAF1BRAFMAPK14 | |
| SCHEMBL4730324 | 0.83 | MAPK14 (0.42) | RAF1BRAFMAPK14 | |
| SCHEMBL4728030 | 0.83 | MAPK14 (0.42) | RAF1BRAFMAPK14MAPTSMN1; SMN2 | |
| SCHEMBL4728338 | 0.83 | RAF1 (0.39) | RAF1BRAFMAPK14ALDH1A1KDM4E | |
| SCHEMBL4729989 | 0.83 | MAPK14 (0.43) | RAF1BRAFMAPK14MAPTSMN1; SMN2 | |
| SCHEMBL4783017 | 0.83 | MAPK14 (0.41) | RAF1BRAFMAPK14 | |
| SCHEMBL4725924 | 0.83 | MAPK14 (0.43) | RAF1BRAFMAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008021388-A1 | HETEROARYL DERIVATIVES AS CYTOKINE INHIBITORS | KEMIA, INC. (US) | 2008-02-21 | — | — | WO | disclosed |